Skip to main content
ACBT logo

ACBT — Investor Relations & Filings

Ticker · 4148 ISIN · KYG0232P1072 TW Manufacturing
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2020-04-10 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 4148

About ACBT

www.allcosmos.com

All Cosmos Bio-Tech Holding Corporation specializes in the application of microbiology to develop and manufacture high-performance bio-chemical fertilizers. Its core products utilize a proprietary formulation combining organic matter, beneficial microorganisms, and chemical elements to enhance soil health and productivity. The company also engages in waste reutilization, applying biotechnological processes to convert organic waste into sustainable resources, and conducts research and development of microbial strains for health care and pharmaceutical applications. By leveraging advanced microbial R&D, the organization provides solutions designed to reduce reliance on traditional chemical inputs and promote circular economy principles. Its activities focus on the synthesis of biological and chemical technologies to provide sustainable alternatives for soil management and resource recovery.

Recent filings

Filing Released Lang Actions
109年3月營業收入
Interim / Quarterly Report Classification · 95% confidence The document is a financial summary report from a company named 全宇生技-KY, providing monthly and cumulative revenue figures in New Taiwan Dollars and Malaysian Ringgit for the period of March 2020 (民國109年03月). The content includes detailed financial data such as net operating revenue for the month and year-to-date, percentage changes compared to the previous year, and exchange rates. The document is relatively short (706 characters) and contains substantive financial data rather than just an announcement or a link to a report. It is not a full annual or interim report but rather a periodic financial summary with actual figures. This fits the definition of an Interim / Quarterly Report (IR), which covers comprehensive financial data for a period shorter than a full fiscal year.
2020-04-10 Chinese
109年3月背書保證與資金貸與
Regulatory Filings Classification · 90% confidence The document is a financial disclosure from a listed company (全宇生技-KY) providing data on fund loans and endorsement guarantees for the current and previous months, including limits and balances. It is a short document (638 characters) presenting specific financial data related to capital loans and guarantees, but it does not contain comprehensive financial statements or management discussion. It appears to be a regulatory disclosure of financial status related to capital and guarantees rather than a full report or announcement of a report. Given the nature of the data and the short length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2020-04-10 Chinese
109年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, managers, and major shareholders, with specific numbers of shares held, pledged shares, and related information. It includes data on shareholdings of board members and senior management, but does not contain financial statements, earnings data, or report narratives. The document is relatively short (3081 characters) and focuses on insider shareholdings rather than financial results or corporate governance policies. This type of document corresponds to a Director's Dealing report, which discloses personal share transactions or holdings by company directors and executives. There is no indication that this is an announcement of a report or a certification, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the best classification is Director's Dealing (DIRS).
2020-04-09 Chinese
109年03月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, managers, and other key personnel, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on personal share transactions and holdings by company insiders. There is no indication of financial results, audit opinions, meeting materials, or other report types. The document is a report of personal share transactions by company directors and executives, which matches the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data on insider shareholdings and transactions.
2020-04-09 Chinese
108年第4季海外子公司投資
Interim / Quarterly Report Classification · 85% confidence The document contains detailed financial data related to investments in overseas subsidiaries, including investment amounts, shareholding percentages, and recognized investment gains or losses for a specific period (108th year, 4th quarter). The content is tabular and financial in nature but does not represent a full annual or quarterly report. It appears to be a detailed financial disclosure related to investment holdings and performance, which is typical of an Interim / Quarterly Report (IR) or a segment of such a report. The document length is 1796 characters, which is relatively short, but it contains substantive financial data rather than just an announcement or certification. There is no indication that this is a full Annual Report (10-K) or an Earnings Release (ER). It is not a regulatory filing or announcement, nor is it a presentation or management discussion. Therefore, the best fit is Interim / Quarterly Report (IR).
2020-03-30 Chinese
代馬來西亞所有子公司公告更新馬國政府「行動管制令」 對本公司營運之影響
Regulatory Filings Classification · 95% confidence The document is a short announcement (810 characters) from a company (全宇生技-KY) regarding the impact of the Malaysian government's movement control order on its subsidiaries' operations. It provides factual updates about operational status and government restrictions but does not contain financial statements, detailed financial data, or comprehensive report content. It is not a full financial report, earnings release, or management discussion. It is a regulatory announcement about operational impact due to external events (COVID-19 related government measures). The document fits best under Regulatory Filings (RNS) as it is a general regulatory announcement without detailed financial or governance content.
2020-03-30 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.